| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/22/2005 | US6967023 solidifying agent consists of a long chain fatty alcohol having at least 15 carbon atoms in its backbone and a fatty acid having at least 18 carbons in its backbone; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 11/22/2005 | US6967019 Production of pancreatic islet cells and delivery of insulin |
| 11/22/2005 | US6967002 Method and apparatus for producing a sterile fluid |
| 11/22/2005 | CA2244767C Process for the production of powdered pulmonary surfactant preparations |
| 11/20/2005 | CA2467894A1 A composition for prevention and treatment of colon adenomas |
| 11/17/2005 | WO2005108981A1 A method of cell isolation |
| 11/17/2005 | WO2005108581A1 Recombinant virus vector for gene introduction in lymphocyte |
| 11/17/2005 | WO2005107817A2 Medical device with coating for capturing genetically-altered cells and methods of using same |
| 11/17/2005 | WO2005107807A2 Cerebral intraventricular transplantation as method of treating amyotrophic lateral sclerosis |
| 11/17/2005 | WO2005107786A1 Therapeutic enzyme formulations and uses thereof |
| 11/17/2005 | WO2005107777A1 Flaxseeds for body weight management |
| 11/17/2005 | WO2005107776A1 METHOD OF ADMINISTERING PORCINE B-DOMAINLESS fVIII |
| 11/17/2005 | WO2005107775A1 Composition having effect of modulating autonomic nerves and method of using the same |
| 11/17/2005 | WO2005107474A2 Oncolytic adenovirus armed with therapeutic genes |
| 11/17/2005 | WO2005065696A8 Pharmaceutical compositions comprising an extract of euphorbia prostrata |
| 11/17/2005 | WO2005030122A3 Inactivated host cell delivery of polynucleotides encoding immunogens |
| 11/17/2005 | US20050256588 Decellularized tissue |
| 11/17/2005 | US20050256326 Process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 11/17/2005 | US20050256077 Gastrointestinal stem cells and uses thereof |
| 11/17/2005 | US20050255593 Bone marrow stromal cell-derived schwann cells |
| 11/17/2005 | US20050255589 Generation of neural stem cells from undifferentiated human embryonic stem cells |
| 11/17/2005 | US20050255588 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 11/17/2005 | US20050255550 Suppression of xenotransplant rejection |
| 11/17/2005 | US20050255454 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy |
| 11/17/2005 | US20050255167 Medicinal Agent for Preventing and Treating Endocrine System Disturbances |
| 11/17/2005 | US20050255166 Composition |
| 11/17/2005 | US20050255125 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 11/17/2005 | US20050255110 Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies |
| 11/17/2005 | US20050255099 Antigenic fusion protein carrying Galalpha 1,3Gal epitopes |
| 11/17/2005 | US20050255097 Modified venom and venom components as anti-retroviral agents |
| 11/17/2005 | US20050255092 an isolated microorganism of the genus Bacillus that is capable of inhibiting escherichia coli disease and improving performance of an animal (pigs); antidiarrhea andantiedemic agents |
| 11/17/2005 | US20050255088 Administering mutant Salmonella sp. for therapy of solid tumor cancer, disrupted msbB gene and is capable of targeting a solid tumor cancer |
| 11/17/2005 | US20050255085 Prevention of recurrence and metastasis of cancer |
| 11/17/2005 | US20050255084 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy |
| 11/17/2005 | CA2566549A1 A method for isolating mammary stem cells |
| 11/17/2005 | CA2565509A1 Recombinant virus vector for gene introduction in lymphocyte |
| 11/17/2005 | CA2564632A1 Flaxseeds for body weight management |
| 11/17/2005 | CA2564443A1 Cancer cell growth inhibition by black bean (phaseolus vulgaris l) extracts |
| 11/17/2005 | CA2563505A1 Protease mixtures for degrading gluten in foodstuffs |
| 11/17/2005 | CA2563329A1 Medical device with coating for capturing genetically-altered cells and methods of using same |
| 11/16/2005 | EP1595546A1 Remedy for cancer |
| 11/16/2005 | EP1594958A2 Activation and expansion of cells |
| 11/16/2005 | EP1594889A2 Nell peptide expression systems and bone formation activity of nell peptide |
| 11/16/2005 | EP1594492A2 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 11/16/2005 | EP1594473A2 Composition and method for treating age-related disorders |
| 11/16/2005 | EP1594433A2 Cancer therapy sensitizer |
| 11/16/2005 | EP1511839A4 Generation of neural stem cells from undifferentiated human embryonic stem cells |
| 11/16/2005 | EP1498129B1 Use of adenoviruses mutated in the va genes for cancer treatment |
| 11/16/2005 | EP1368419B1 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 11/16/2005 | EP1319082B1 Expression vectors containing hybrid ubiquitin promoters |
| 11/16/2005 | EP1292319B1 Extracts from spermatophyte plants with antitumor activity |
| 11/16/2005 | EP1218017B1 Combination of a statin and ex-vivo treated blood for treating atherosclerosis |
| 11/16/2005 | EP1131090B1 Use of paraoxanase-1 (pon-1) to decrease atheroma formation and hypercholesterolemia |
| 11/16/2005 | EP1100515B1 EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 11/16/2005 | EP1049479B1 Analgesic from snake venom |
| 11/16/2005 | EP1019493B1 Generation of hematopoietic cells from multipotent neural stem cells |
| 11/16/2005 | EP0477295B2 Platelet aggregation inhibitors |
| 11/16/2005 | CN1697879A Biomolecule transfer method using virus envelope and composition and system therefor |
| 11/16/2005 | CN1697658A Fermentation product and process for producing the same |
| 11/16/2005 | CN1695638A Probiotic therapy of neonatal meningitis and method of using e. coli virulence determinatns |
| 11/16/2005 | CN1695637A Method for preparing jujube-iron oral taking fluid mixed with boiling water |
| 11/16/2005 | CN1227356C Application of substrate cell derived from fat tissue |
| 11/16/2005 | CN1227354C Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| 11/16/2005 | CN1227026C Method for using silkworm to express human interleukin 11 to produce medicine |
| 11/15/2005 | US6965018 Antibodies directed to B7-related polypeptide, BSL-2 |
| 11/15/2005 | US6965016 Antagonist for use in the prevention of fertility in humans and animals |
| 11/15/2005 | US6965014 Bioerodible film; mixture of thrombin and fibrinogen; controlling coagulation; drug delivery of antitumor, anticancer agents |
| 11/15/2005 | US6964869 Polypeptides; detecting infections using antibodies |
| 11/15/2005 | CA2437962C Method of extracting virus from cell culture |
| 11/10/2005 | WO2005105996A1 A pax-encoding vector and use thereof |
| 11/10/2005 | WO2005105992A1 Chondrocyte culture formulations |
| 11/10/2005 | WO2005105981A2 Method and system for reinnervation of muscle |
| 11/10/2005 | WO2005105833A2 Novel herpes simplex viruses and uses thereof |
| 11/10/2005 | WO2005105130A1 Novel therapeutic usage of factor derived from pigment epithelium, capable of inhibiting nadph oxidase activity |
| 11/10/2005 | WO2005105121A1 Use of platelets or platelet rich plasma (prp) |
| 11/10/2005 | WO2005104790A2 Treatment of muscular dystrophy with mobilized peripheral blood pluripotent cells |
| 11/10/2005 | WO2005065693A3 Use of cathepsin z inhibitors for the treatment of rheumatoid arthritis and other autoimmune diseases |
| 11/10/2005 | WO2005016231A3 Agents and methods for treatment of disease by oligosaccharide targeting agents |
| 11/10/2005 | WO2003082201A3 Collagen biofabric and methods of preparation and use therefor |
| 11/10/2005 | US20050250718 Pharmaceutical- or gene-carrier compositions with reduced hemagglutinating activity |
| 11/10/2005 | US20050250698 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 11/10/2005 | US20050250697 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 11/10/2005 | US20050250693 Metalloproteinase inhibitors |
| 11/10/2005 | US20050250203 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 11/10/2005 | US20050250202 Adipose stromal stem cells for tissue and vascular modification |
| 11/10/2005 | US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 11/10/2005 | US20050250175 Bacterial cell wall skeleton component preparaion |
| 11/10/2005 | US20050250161 inducing tolerance to xenograft tissue or organ; tolerogenic antigen presenting cells (APC) which overexpress monocyte inhibitory receptor (MIR); generating antigen specific allospecific human-suppressor CD8+CD28- T cells; detecting expression of ILT3, ILT4, ILT2 protein; autoimmune diseases; host cell |
| 11/10/2005 | US20050249831 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 11/10/2005 | US20050249815 Process for producing a plasma protein-containing medicament |
| 11/10/2005 | US20050249783 Method of improving absorption of vitamin e by a pet animal |
| 11/10/2005 | US20050249756 Use of human prostate cell lines in cancer treatment |
| 11/10/2005 | US20050249731 Methods of implating mesenchymal stem cells for tissue repair and formation |
| 11/10/2005 | US20050249720 Cosmetic skin formulation |
| 11/10/2005 | US20050249719 Using glutenase mixture for treatment and prevention of celiac sprue and/or dermatitis herpetiformis |
| 11/10/2005 | US20050249712 Methods for use of TSLP and agonists and antagonists thereof |
| 11/10/2005 | US20050249708 Cerebral Intraventricular Transplantation as Method of Treating Amyotrophic Lateral Sclerosis (ALS) |
| 11/10/2005 | US20050249707 Stimulating an immune response in human or animal, by administering a gene, infected DENDRITIC CELLS; without preventing antigen processing occurring within the infected cell; increase gene expression on the surface of tumour cells; protection against cancer; vaccines |
| 11/10/2005 | US20050249706 Using transgenic and attenuated salmonella comprising tumor modulatory proteins and pharmceutical conjugate to treat cell proliferative disorders; targeted tissue therapy |
| 11/10/2005 | US20050249705 Inactivated herpes simplex virus glycoprotein for treating metastasis; ultraviolet radiation and heating; highly safe |